PDCD1 and neoplasm: Furthermore, F Strassheimer et al. have demonstrated that combining CAR-NK cells with anti-PD-1 antibody enhances the cytotoxic T lymphocytes infiltration in the tumor site leading to a primed immune response and high tumoricidal activity against advanced-stage glioblastoma [270].